These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10485217)

  • 1. [From science to clinical practice. Risk assessment in relation to treatment and prevention].
    Lauritzen T; Mainz J; Lassen JF
    Ugeskr Laeger; 1999 Jun; 161(24):3633-8. PubMed ID: 10485217
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
    Reynolds TM
    J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Make each patient count.
    Berry JA; Coverston CR; Williams M
    Nurse Pract; 2008 Feb; 33(2):42-7. PubMed ID: 18300791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical screening and the value of early detection. When unwarranted faith leads to unethical recommendations.
    Malm HM
    Hastings Cent Rep; 1999; 29(1):26-37. PubMed ID: 10052009
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for osteoporosis in postmenopausal women: recommendations and rationale.
    Berg AO
    Am J Nurs; 2003 Jan; 103(1):73-80; discussion 81. PubMed ID: 12544063
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of cancer prevention.
    Greenwald P
    Semin Oncol Nurs; 2005 Nov; 21(4):296-8. PubMed ID: 16293518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. What other STI testing should we do for a patient with chlamydia?
    Patel M; Corboy JE; Hitchcock K; Kilgore DB
    J Fam Pract; 2007 Jan; 56(1):64-6. PubMed ID: 17217903
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 10. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When the population approach to prevention puts the health of individuals at risk.
    Adams J; White M
    Int J Epidemiol; 2005 Feb; 34(1):40-3. PubMed ID: 15256526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment.
    Chamberlain KL
    J Am Acad Nurse Pract; 2005 Mar; 17(3):90-5. PubMed ID: 15748221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health risk assessment and risk prevention are the main goals in environmental and occupational areas of science, public health policy and practice.
    Int J Occup Med Environ Health; 2004; 17(1):3-4. PubMed ID: 15212200
    [No Abstract]   [Full Text] [Related]  

  • 14. Nursing intervention and older adults who have cancer: specific science and evidence based practice.
    Bourbonniere M; Kagan SH
    Nurs Clin North Am; 2004 Sep; 39(3):529-43. PubMed ID: 15331300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening: new guidance on what and what not to do.
    Campos-Outcalt D
    J Fam Pract; 2007 Jun; 56(6):461-4. PubMed ID: 17543256
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the health of Oklahomans through clinical prevention, part II: Screening to identify early-stage disease and risk factors.
    Crutcher JM; DeRose DJ; DePersio SR
    J Okla State Med Assoc; 2000 Aug; 93(8):397-408. PubMed ID: 10979617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure ulcer prevention and treatment. Part I--prediction and prevention.
    J Pract Nurs; 2006; 56(2):5-10; quiz 11-2. PubMed ID: 16986475
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention and screening of gastrointestinal cancers.
    Mahon SM
    Semin Oncol Nurs; 2009 Feb; 25(1):15-31. PubMed ID: 19217503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of fracture risk: who should be treated for osteoporosis?
    van der Klift M; de Laet CD; Pols HA
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):937-50. PubMed ID: 16301188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.